Late luteal phase dydrogesterone in combination with clomiphene or tamoxifen in the treatment of infertility associated with irregular and infrequent menstruation: enhancing patient compliance.

@article{Viniker1996LateLP,
  title={Late luteal phase dydrogesterone in combination with clomiphene or tamoxifen in the treatment of infertility associated with irregular and infrequent menstruation: enhancing patient compliance.},
  author={D. Viniker},
  journal={Human reproduction},
  year={1996},
  volume={11 7},
  pages={
          1435-7
        }
}
  • D. Viniker
  • Published 1996
  • Biology, Medicine
  • Human reproduction
This pilot study was undertaken to determine whether dydrogesterone administered in the late luteal phase might have a potential benefit for infertility associated with irregular and infrequent menstruation. Between April 1994 and February 1995, 54 normo-prolactinaemic women received either tamoxifen, if there was evidence of polycystic ovaries and/or increased luteinizing hormone (LH) secretion, or clomiphene together with dydrogesterone 10 mg twice daily on days 21-26 of the menstrual cycle… Expand
6 Citations
Hypothesis on the role of sub-clinical bacteria of the endometrium (bacteria endometrialis) in gynaecological and obstetric enigmas.
TLDR
The hypothesis that one common factor, bacteria endometrialis, could provide a plausible explanation for a variety of obstetric and gynaecological mysteries is particularly intriguing and there is sufficient evidence to justify further investigation. Expand
Cyclic changes in serum levels of insulin-like growth factor binding protein-1 in women treated with clomiphene citrate and tamoxifen
  • Hongshun Wang, T. H. Wang, Y. Soong
  • Biology, Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2000
TLDR
The preovulatory peak of circulating IGFBP-1 can be induced in cycles treated with both clomiphene citrate and tamoxifen and indicates that IGF BP-1 may also reflect follicular development and may further be used as an additional indicator to monitor folliculogenesis under clomine citrate treatment. Expand
The steroid hormone dydrogesterone inhibits myometrial contraction independently of the progesterone/progesterone receptor pathway
TLDR
The results suggested that the rapid and direct effects of dydrogesterone on myometrial contraction were caused by a nongenomic pathway and that the progesterone receptor was not required for dYDrogestersterone action. Expand
Primary care management of abnormal uterine bleeding
Study selection Randomised controlled trials that evaluated non-surgical interventions for non-pregnant women with irregular or abnormal cyclic uterine bleeding for three months or more were eligibleExpand
Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women
TLDR
The use of infertility’s treatment is limited in Morocco and outside of medical coverage, the infertility management requires permanent efforts, financial supports, psychological assistance and serious dialogue between all the stakeholders. Expand
Identification of tamoxifen and metabolites in human male urine by GC/MS.
TLDR
A method for identification of tamoxifen and metabolites in urine, using the gas chromatography and mass spectrometry system (GC/MS) is described. Expand

References

SHOWING 1-10 OF 21 REFERENCES
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome
TLDR
It is concluded that a continuous oestradiolprogestogen combination can be used for long-term treatment of climacteric complaints in postmenopausal women and that after 4 months the clinical efficacy is the same irrespective of the type and dose of progestogen administered. Expand
Dehydrogesterone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency.
TLDR
It is concluded that both P and dehydrogesterone can be used to advantage in the treatment of luteal phase defects, and therapy with dehydroGESterone does not alter the normal pattern of endometrial secretion. Expand
Tamoxifen: an alternative approach in clomiphene resistant polycystic ovarian syndrome patients.
TLDR
Twenty patients with ultrasound diagnosed polycystic ovaries and high luteinizing hormone levels who failed to respond to clomiphene citrate were given tamoxifen to induce ovulation and three pregnancies were achieved while there was no pregnancy in group 1. Expand
Comparison between tamoxifen and clomiphene for induction of ovulation.
TLDR
Tamoxifen is just as effective as clomiphene in inducing ovulation in women with anovulation, according to a comparison of the effectiveness of the two drugs in treating anovulatory infertility. Expand
Comparison between tamoxifen and clomiphene for induction of ovulation.
TLDR
Tamoxifen is just as effective as clomiphene in inducing ovulation in women with anovulatory infertility, compared with both drugs in an alternate way. Expand
Action of tamoxifen on folliculogenesis in the menstrual cycle of infertile patients.
TLDR
The results suggest that the mechanism of tamoxifen in improving folliculogenesis may involve a direct action on the ovary without intervention of the hypothalamic-pituitary system. Expand
Hypersecretion of luteinising hormone, infertility, and miscarriage
TLDR
An important role for hypersecretion of LH before conception in miscarriage is indicated, and this finding offers the possibility of a simple predictive test for women before pregnancy, and could also be used to identify patients with an endocrine abnormality that can be remedied. Expand
A clomiphene citrate and tamoxifen citrate combination therapy: a novel therapy for ovulation induction.
TLDR
Clomiphene citrate/tamoxifen is a novel treatment modality of ovulation induction with high efficacy and was more effective in Ovulation induction than CC. Expand
Ovulation and pregnancy rates with clomiphene citrate.
TLDR
Clomiphene citrate administered at high doses (150 mg and 200 mg) is effective in inducing ovulation in women who would otherwise have failed to conceive if treatment were restricted to only lower dosage regimens. Expand
Reduced in‐vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase
TLDR
A significant reduction in the fertilization rate of mature oocytes was observed in those patients whose basal serum LH values were >1 SD above the mean, which may be a reflection of premature oocyte maturation or ageing. Expand
...
1
2
3
...